Inactive Instrument
Tobira Therapeutics Inc Stock
Stocks
US88883P1012
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | - |
Scott Reents
DFI | Director of Finance/CFO | 59 | - |
| Corporate Secretary | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.79% | -2.27% | +43.23% | +88.96% | 67.98B | |
| -2.06% | -0.18% | +39.67% | +86.44% | 64.94B | |
| -0.31% | +6.54% | -12.96% | +378.92% | 27.58B | |
| -3.00% | -2.90% | +33.13% | +12.54% | 25.74B | |
| +0.86% | +1.65% | -7.74% | -14.95% | 26.06B | |
| -1.46% | +0.42% | +23.61% | -18.61% | 20.09B | |
| -2.96% | -15.21% | +216.20% | +368.10% | 17.16B | |
| -1.49% | -4.88% | -6.60% | +531.89% | 14.92B | |
| -0.20% | +8.37% | +55.78% | +164.98% | 14.62B | |
| Average | -1.38% | +0.26% | +42.70% | +177.58% | 31.01B | |
| Weighted average by Cap. | -1.52% | +0.18% | +38.37% | +137.35% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
